SCLX
NASDAQ · Pharmaceuticals
Scilex Holding Co
$7.52
-0.28 (-3.59%)
Open$7.90
Previous Close$7.80
Day High$7.90
Day Low$7.28
52W High$34.27
52W Low$3.60
Volume—
Avg Volume30.1K
Market Cap66.23M
P/E Ratio—
EPS$-29.41
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+412.4% upside
Current
$7.52
$7.52
Target
$38.53
$38.53
$25.32
$38.53 avg
$55.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 120.82M | 99.19M | 16.86M |
| Net Income | -155,437,743 | -114,855,475 | 3.00M |
| Profit Margin | -128.7% | -122.2% | 17.8% |
| EBITDA | -169,438,426 | -132,156,407 | 6.50M |
| Free Cash Flow | — | — | 2.15M |
| Rev Growth | +21.8% | +21.8% | +5.1% |
| Debt/Equity | — | — | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |